![]() | Only 14 pages are availabe for public view |
Abstract Adequate sexual function is essential for adult relationship and provides a sense of physical, physiological and social well-being. Many hormones and neurotransmitters as dopamine and serotonin play a role in maintaining normal sexual function (Baldwin et al., 1997). Laumann and co-workers (1999) found that sexual dysfunction in general population is more prevalent in women (43%) than men (31%), using latent class analysis, symptoms could be grouped into three categories. in women, there were low sexual desire (22%) arousal problems (14%) and sexual pain (7%): in men, premature ejaculation (21%), erectile dysfunction (5%), and low sexual desire (5%). Treatment-emergent sexual dysfunctions have been described as the unspoken side effect of antipsychotics. a comparative study of men with schizophrenia treated with either conventional and atypical antipsychotics found that atypical group was associated with significant better sexual function (Aizenberg et al., 2001). Treatment-emergent sexual dysfunction can occur with tricyclic antidepressants, SSRIs and MAOIs, some antidepressants as bubropion, mirtazapine and nefazodone may have a lower incidence of sexual dysfunction (Baldwin, 2001). Several studies have proclaimed that stopping the antidepressant, adding on another antidepressant or changing it may resolve this problem (Norden, 1994). Aim of work : 1- Investigate the different underlying pathology of the problem caused by each group medication. 2- Estimate the size of the problem caused by psychotropic medications. 3- Search for different up-to-date methods of management of the problem. |